Search results

Jump to navigation Jump to search
  • [[Category:Neuropathology tumours]] [[Category:WHO grade III tumours]]
    118 bytes (12 words) - 15:01, 21 October 2015
  • [[Category:Neuropathology tumours]] [[Category:WHO grade III tumours]]
    125 bytes (12 words) - 15:02, 21 October 2015
  • [[Category:Neuropathology tumours]] [[Category:WHO grade III tumours]]
    124 bytes (12 words) - 10:40, 20 May 2016
  • *Oligoastrocytoma, NOS (Grade II WHO; ICD-O: 9382/3) *Anaplastic Oligoastrocytoma, NOS (Grade III WHO; ICD-O: 9382/3)
    2 KB (277 words) - 10:38, 20 May 2016
  • | Prognosis = poor (analog to WHO Grade III) '''Anaplastic pilocytic astrocytoma''', abbreviated '''APA''', is a rare high-grade [[astrocytoma]]. It can develop from a [[pilocytic astrocytoma]].
    5 KB (607 words) - 13:25, 19 October 2017
  • ...use astrocytomas. An overview of other CNS tumours is found in the ''[[CNS tumours]]'' article. * Common vs. uncommon tumours.
    12 KB (1,444 words) - 11:28, 13 April 2022
  • *Poor prognosis - WHO grade III.<ref name=pmid20644273>{{Cite journal | last1 = Menon | first1 = G. | last *[[Neuropathology tumours]].
    3 KB (333 words) - 06:20, 10 December 2014
  • '''Anaplastic astrocytoma''' (AKA: ''high-grade astrocytoma'') is a infiltrating neoplasm of the diffuse astrocytic and oli * Most common grade III WHO glioma in adults (peaks between 40-50 years).
    7 KB (840 words) - 09:24, 19 March 2018
  • ...= [[soft tissue lesions|soft tissue]] - [[fibroblastic/myofibroblastic tumours]], pleura ...esion|soft tissue tumour]] that fits in the [[fibroblastic/myofibroblastic tumours]]. It is usually benign.
    8 KB (955 words) - 07:21, 15 December 2016
  • *Moderately aggressive (WHO Grade II).<ref name=pmid11465399>{{Cite journal | last1 = Fouladi | first1 = M. *Anaplastic PXA (grade III) - rare. <ref>{{Cite journal | last1 = Louis | first1 = DN. | last2 = Perr
    7 KB (920 words) - 12:38, 11 October 2019
  • Tumours:<ref name=pmid20971711>{{cite journal |author=Gaillard F, Jones J |title=Ma *Primary pineal tumours ~15% of (pineal) tumours - benign to malignant:<ref name=pmid21057132>{{cite journal |author=Smith A
    12 KB (1,634 words) - 17:20, 25 March 2021
  • | Site = [[neuropathology tumours]] - cerebral hemispheres, posterior fossa (rare), spinal cord (very rare) | Prognosis = moderate - dependent on grade
    16 KB (1,953 words) - 09:32, 6 April 2022
  • ...related to [[pilocytic astrocytoma]]. The future WHO classification of CNS tumours will include it as separate entity. ...assigned. Molecular class MC-1 corresponds to WHO I, class MC-2 to WHO II/III<ref name="pmid29766299">{{cite journal |authors=Deng MY, Sill M, Chiang J,
    9 KB (1,148 words) - 17:20, 25 March 2021
  • This article covers '''fibroblastic/myofibroblastic tumours'''. These tumours fit into the larger category of [[soft tissue lesions]]. =List of tumours=
    20 KB (2,365 words) - 18:58, 24 March 2019
  • | Caption = Ependymoma grade II WHO. [[H&E stain]] | Prognosis = intermediate to poor (WHO Grades II & III)
    16 KB (1,962 words) - 12:56, 12 April 2022
  • ...skochil DH |title=Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in spo *grade IV: Presence of necrosis (3/4 of all MPNST).
    12 KB (1,493 words) - 09:28, 27 April 2017
  • | Prognosis = good (WHO Grade I) *Gangliolioma: Grade I WHO mixed neuronal-glial tumour (ICD-O code: 9505/1).
    11 KB (1,340 words) - 09:01, 4 April 2022
  • ...Tumours are a large part of [[neuropathology]]. [[Cytopathology]] of CNS tumours is dealt with in the article ''[[CNS cytopathology]]''. There are separate articles for ''[[peripheral nerve sheath tumours]]'' and ''[[pituitary gland|pituitary/peri-pituitary lesions]]''.
    33 KB (3,993 words) - 09:04, 14 April 2022
  • ...acyte-rich, metaplastic), Grade II (invasive, clear cell, chordoid), Grade III (papillary, rhabdoid) | Site = see ''[[CNS tumours]]''
    31 KB (3,903 words) - 14:29, 20 November 2019